What is USPSTF's stance on depression screening in adults?

• A. Recommends screening for major depressive disorder in adults, with appropriate follow-up and treatment resources
• B. Not recommended
• C. Only for patients with chronic illness
• D. Screening is optional and not linked to treatment

Answer: (A)

The main idea is that USPSTF recommends routine screening for major depressive disorder in adults in primary care when there are adequate systems for diagnosis, treatment, and follow-up. This matters because screening by itself only flags potential cases; the real benefit comes when a positive screen is followed by confirmatory assessment and access to evidence-based treatment and ongoing monitoring. Validated tools like the PHQ-2 or PHQ-9 are used to identify symptoms, and with prompt follow-up and treatment resources—such as psychotherapy, medications, or collaborative care—the balance of benefits over harms is favorable. The other statements don’t fit because screening isn’t dismissed or optional, it isn’t limited to people with chronic illness, and it is specifically linked to having treatment and follow-up in place.